Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-01

Clinical Trial Update: A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial assessing LCZ696 (sacubitril/valsartan) effect on aortic stiffness in hypertension; completed with posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LCZ696 (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2016-09-01